Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Long‐term efficacy and safety of risankizumab for the treatment of moderate‐to‐severe plaque psoriasis: interim analysis of the LIMMitless open‐label extension trial beyond 3 years of follow‐up
Kim Alexander Papp, Mark Lebwohl, L. Puig, Mamitaro Ohtsuki, Stefan Beissert, Jinru Zeng and 6 more
- Rank
- 46 of 851
- Percentile
- top 5.5%
- Where
- British Journal of Dermatology, 2021
- Citations
- 51
From the 2021 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.